Trials / Completed
CompletedNCT05160350
Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy
Investigation of Probiotic Effect on Seizure Frequency of Adult Patients With Drug-resistant Epilepsy; A Randomized Double-blind Parallel Placebo-controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Mazandaran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, double-blind parallel group placebo-controlled clinical trial with the aim of investigating the effect of probiotic versus placebo on drug-resistant adult patients with epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Probiotic | Each probiotic capsule contained combination of lactobacillus and Bifidobacterium species. |
Timeline
- Start date
- 2021-04-21
- Primary completion
- 2021-10-23
- Completion
- 2021-10-30
- First posted
- 2021-12-16
- Last updated
- 2022-01-11
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT05160350. Inclusion in this directory is not an endorsement.